35 research outputs found

    High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetes clinic

    Get PDF
    Objective: To determine the prevalence of liver function test abnormalities in South African black and Indian adult patients with type 2 diabetes mellitus attending a tertiary diabetes clinic. iabetes clinic. Recorded data included the past medical and drug history, history of alcohol abuse, anthropometry, lipid profile and liver function tests. Results: The charts of 313 patients were reviewed. Liver function test abnormalities were found in 146 patients (46.6%). Of these,15 patients had a history of alcohol abuse, or a past medical history that might explain the abnormality, and these patients were excluded from further analysis. Elevations in serum gamma-glutamyl transferase, alkaline phosphatase and alanine transaminase were found in 25.2% (n = 79), 23.3% (n = 73) and 15.3% (n = 48), respectively. Serum total cholesterol, triglycerides and low-density lipoprotein cholesterol were higher in the group with liver function test abnormalities when compared with subjects with normal results. Mean body mass index was similar in the two groups (32.5 vs. 33.2 kg/m2). Although morbidly obese patients (n = 42) demonstrated the highest frequency of liver enzyme derangements (54.8%), this was not statistically significant. Conclusion: There is a high prevalence of liver function test abnormalities in this group of patients with type 2 diabetes, and this is particularly so in the morbidly obese subjects. This is comparable with the reported prevalence in the Western world. Lipid abnormalities were more frequent in the group with liver enzyme derangements.Keywords: South African, type 2 diabetes, abnormal liver enzymes, prevalenc

    Evaluation of phosphorus fertilizer rates for maize and sources for cowpea on different soil types in southwestern Nigeria

    Get PDF
    Flexible phosphorus (P) fertilizer rate recommendation could be based on variations in soil characteristics that affect yield responses. Experiments were conducted in the Department of Agronomy, LAUTECH, on the effects of P rates on maize and P sources on cowpea in four soil types. On average, soil types and P rates influenced maize height and grain yield. Iwo and Egbeda soils supported taller plants than Itagunmodi soil. Phosphorus fertilization enhanced height and grain yield compared with no P. To optimize maize grain yield for Itagunmodi and Egbeda soils, application of 15 kg P2O5 ha-1 was sufficient while for Majeroku and Iwo, it was 30 and 75 kg P2O5 ha-1, respectively. Cowpea grain yield and P uptake were significantly affected by soil types and P sources. Iwo and Egbeda soils supported higher grain weights and P uptake than Itagunmodi and Majeroku soils. Triple super phosphate (TSP) and no P supported higher grain weights and P uptake than rock phosphate (RP) and single super phosphate (SSP)

    Organic Residues Affect Soil P Availability, Cowpea Yield And Nutrient Uptake on a Near Neutral P-Deficient Alfisol in Southwestern Nigeria

    Get PDF
    In the moist savanna zone of West Africa, it has been suggested that application of organic residues may play central roles in increasing the availability of inherent soil phosphorus and the dissolution and utilization of phosphate rock (PR) by food crops. Laboratory incubation study was carried out with plant residues of different chemical compositions (leaves of Flemingia macrophylla, Leucaena leucocephala, and maize stover (Zea mays L.) in pots containing a P-deficient Alfisol from SW Nigeria with ground Togo PR for 3 months to determine the dynamics of Olsen extractable P in the absence of growing plants. Cowpea (Vigna unguiculata L. Walp) was planted in the incubated soils thereafter to evaluate treatment effects on cowpea yield and P uptake. A control treatment (no PR, no plant residues) was included for comparison. The pot trial was laid out as completely randomised design replicated four times. Generally, soil P availability increased with increasing length of incubation. Compared with the initial soil P value of 3.14 mg kg-1, after 12 weeks of incubation Leucaena +PR had the highest soil P (9. 9 mg kg soil-1), followed by Flemingia (7.9 mg kg soil-1) and Flemingia + PR (7.3 mg kg soil-1). Phosphorus availability following incubation of PR was 5.11 mg kg soil-1, 4.2 mg kg soil-1 for the control treatment, and 3.37 mg kg soil-1 for maize stover, which rather immobilized P throughout the incubation period. Cowpea plants grown on Flemingia and Leucaena incubated soils with and without PR produced higher number of pods, grain yield, and shoot dry matter than those grown on PR and maize+PR incubated soils. Total N uptake was not significantly different among the treatments but P and K uptake was significantly higher in plants grown on Leucaena+PR, Leucaena, Flemingia, and Flemingia+PR incubated soils than those grown on the control, PR, and maize+PR incubated soils. These results suggest that plant residues can be selected and incubated in near neutral P-deficient soils to enhance P availability and increase crop yield and P uptake.Key words: Alfisol, cowpea dry matter, length of incubation, Olsen extractable P, plant residues, Togo rock phosphate, West Afric

    Serum C-Reactive Protein in Nigerians With Type 2 Diabetes Mellitus

    Get PDF
    Background: C-reactive protein is an acute-phase proteins, produce in the liver, its release is stimulated by cytokines (interleukin 6 and tumour necrosis factor alpha). Elevated level of it is a risk factor for coronary heart disease. Baseline levels of C-reactive protein in apparently healthy men and women predict long-term risk of a first myocardial infarction. Diabetics are at increased risk for coronary heart disease, data from the Framingham Study showed a two-to three-fold elevation in the risk of clinically evident atherosclerotic disease in patients with type II diabetes compared to those without diabetes. However, but data regarding CRP in Nigerian diabetic is lacking.Method: A cross-sectional study conducted among patients attending out patient clinic of the Obafemi Awolowo University Teaching Hospitals complex (OAUTHC) Ile Ife, Osun State south western Nigeria. Measurement of C-reactive protein was based on the principle of solid phase enzyme-linked immunosorbent assay (ELISA).Results: A total of 125 consecutive subjects were recruited comprising 75 patients with type II diabetes mellitus with or without hypertension and 50 apparently healthy age-and-sex comparable controls. There was a significant difference between the mean systolic and diastolic blood pressures of the patients and controls. The fasting blood glucose and C-reactive protein were significantly higher in diabetics compared to controls. There was a positive and significant correlation between FBG and CRP in both patients and controls. Conclusion: This study showed that diabetics have significantly higher serum C-reactive protein compared to the apparently controls. Also there was a positive and significant correlation between C-reactive protein and fasting blood glucose among both patients and controls

    Seroprevalence of Hepatitis C Virus Infection in Nigerians with Type 2 Diabetes Mellitus

    Get PDF
    Background: Several studies have suggested a strong epidemiologic association between Diabetes Mellitus (DM) and Hepatitis C Virus (HCV) infection in some populations. However, the reasons why chronic HCV infection is prevalent in DM remain unknown. Our aims were to determine the prevalence of HCV infection in a population of Nigerian diabetics compared with the general population as well as assess the influence of sex and age on HCV infection in the same diabetic population. Design and Methods: A total of 115 diabetic patients were compared with 2,301 blood donors matched by recognized risk factors to acquire HCV infection. Serologic testing for anti HCV was done using a commercial enzyme-linked immunosorbent assay (ELISA) kits. Results: Sixty (60) type 2 diabetic patients were males while fifty-five (55) were females. Their mean age was 55.4 ± 9 years and mean blood glucose level was 8.5mmol/l. One subject tested positive for HCV infection. The control group consisted of 2,031 adults recruited from the blood donor\'s clinic. Forty five of them (2.2%) tested positive for HCV. Conclusion: Our preliminary results suggest a low sero-prevalence of HCV infection among our patients with type 2 diabetes. Presently, routine screening for HCV infection in persons with diabetes may not be necessary. Keywords: HCV infection, type 2 diabetes mellitus Nigerian Journal of Clinical Practice Vol. 11 (3) 2008: pp. 199-20

    A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase

    Get PDF
    Human norovirus is the leading cause of acute gastroenteritis worldwide, affecting every year 685 million people. In about one third of cases, this virus affects children under five years of age, causing each year up to 200,000 child deaths, mainly in the developing countries. Norovirus outbreaks are associated with very significant economic losses, with an estimated societal cost of 60 billion dollars per year. Despite the marked socio-economic consequences associated, no therapeutic options or vaccines are currently available to treat or prevent this infection. One promising target to identify new antiviral agents for norovirus is the viral polymerase, which has a pivotal role for the viral replication and lacks closely homologous structures in the host. Starting from the scaffold of a novel class of norovirus polymerase inhibitors recently discovered in our research group with a computer-aided method, different new chemical modifications were designed and carried out, with the aim to identify improved agents effective against norovirus replication in cell-based assays. While different new inhibitors of the viral polymerase were found, a further computer-aided ligand optimisation approach led to the identification of a new antiviral scaffold for norovirus, which inhibits human norovirus replication at low-micromolar concentrations.status: Published onlin

    The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

    Get PDF
    INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century
    corecore